✦ LIBER ✦

A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer

✍ Scribed by Charles Butts; R. Nevin Murray; Colum J. Smith; Peter M. Ellis; Kevin Jasas; Andrew Maksymiuk; Glenwood Goss; Guy Ely; Frank Beier; Denis Soulières

Book ID: 119935653
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 115 KB
Volume: 11
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2010.n.101

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

INSPIRE: A phase III study of the BLP25

INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer

✍ Yi-Long Wu; Keunchil Park; Ross A Soo; Yan Sun; Karin Tyroller; David Wages; Guy 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 259 KB

An open-label, prospective phase I/II st

An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer

✍ Meyer, Ralf G.; Korn, Stephanie; Micke, Patrick; Becker, Kai; Huber, Christoph; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 216 KB

A phase II, randomized, multicenter stud

A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer

✍ Christos Chouaid; Faith Nathan; Kristine Pemberton; Thomas Morris 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 244 KB

A multicenter phase II study of cetuxima

A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer

✍ Ramalingam, S.S.; Kotsakis, A.; Tarhini, A.A.; Heron, D.E.; Smith, R.; Friedland 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 740 KB

Randomized, Multicenter, Open-Label Phas

Randomized, Multicenter, Open-Label Phase II Study of Gemcitabine plus Single-Dose Versus Split-Dose Carboplatin in the Treatment of Patients with Advanced-Stage Non-Small-Cell Lung Cancer

✍ Wolfgang Schuette; Thomas Blankenburg; Claus-Peter Schneider; Ludwig Fischer von 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 142 KB

Retreatment of gefitinib in patients wit

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

✍ Oh, In-Jae; Ban, Hee-Jung; Kim, Kyu-Sik; Kim, Young-Chul 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB